Skip to content

Form 4 filed by Hansen Gwenn

Hansen Gwenn filed this Form 4 on NRIX (Nurix Therapeutics, Inc.) with 10 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-03 00:42:20 UTC.

Accession
0001817160-26-000023
Filed
2026-11-02
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: NRIX · Nurix Therapeutics, Inc. (CIK 1549595)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-10-30M exercised+3,750$0120,977D
Common Stock 2026-10-30M exercised+2,859$0123,836D
Common Stock 2026-10-30M exercised+3,573$0127,409D
Common Stock 2026-10-30S sold-3,957$26.2791123,452D
Common Stock 2026-11-02M exercised+1,452$1.86124,904D
Common Stock 2026-11-02S sold-1,452$26.8123,452D
Restricted Stock Units derivative2026-10-30M exercised-3,750$07,500D
Restricted Stock Units derivative2026-10-30M exercised-2,859$017,150D
Restricted Stock Units derivative2026-10-30M exercised-3,573$035,730D
Employee Stock Option (right to buy) derivative2026-11-02M exercised-1,452$057,954D